CBST

Cubist Pharmaceuticals, Inc. News Headlines

$75.65
*  
0.69
0.92%
Get CBST Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading CBST now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Cempra Poised To Join Antibacterial Drug Acquisition Buzz With Upcoming Data Release
11/25/2014 8:00:00 AM - Seeking Alpha


3 Fast-Growing Biotech Stocks To Buy in December
11/24/2014 10:46:03 AM - Motley Fool


Is This Superbug Drug Company Right for Your Portfolio?
11/19/2014 12:08:00 PM - Fox Business


Staples Q3 14 Earnings Conference Call At 8:00 AM ET
11/19/2014 7:00:00 AM - RTT News


Cubist Pharma. To Present At Jefferies Conference; Webcast At 8:00 AM ET
11/19/2014 7:00:00 AM - RTT News


Making Money With Charles Payne: 11/17/14
11/17/2014 6:00:00 PM - Fox Business


5 Things Actavis plc's Management Wants You to Know
11/12/2014 9:21:04 AM - Motley Fool


ETF Outlook: First Trust Amex Biotech Index Fund ETF (FBT)
11/6/2014 8:32:36 AM - Marc Chaikin


Cubist Pharmaceuticals (CBST) Upgraded From Hold to Buy
11/5/2014 9:14:00 AM - TheStreet


Why We Think Cubist Pharmaceuticals Has Incredible Upside
10/29/2014 4:34:00 AM - Seeking Alpha


3 States With the Worst Hospital Infection Rates
10/26/2014 11:02:02 AM - Motley Fool


Cubist Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for CBST
10/22/2014 3:27:42 PM - BNK Invest


Cubist Pharmaceuticals Inc's Momentum Builds As Anti-Infection Product Line Grows
10/22/2014 7:00:02 AM - Motley Fool


Cubist Pharma Turns To Profit In Q3, Results Beat View
10/21/2014 9:17:00 PM - RTT News


Cubist Pharma Reports Q3 Non-GAAP EPS Of $0.58 - Quick Facts
10/21/2014 4:15:00 PM - RTT News


Cubist Pharmaceuticals Q3 14 Earnings Conference Call At 5:00 PM ET
10/21/2014 3:00:00 PM - RTT News


Sector Update: Health Care Stocks Rising; Drug-Makers Said Still Talking Merger, Absent AbbVie
10/20/2014 12:56:44 PM - MT Newswires


Sector Update: Health Care
10/20/2014 12:50:43 PM - MT Newswires


Cubist Pharma Names COO Robert Perez CEO
10/20/2014 7:56:00 AM - RTT News


InsiderInsights.com Daily Round Up 10/2/14: FGP, INFI, AGCO, OPK
10/3/2014 10:14:00 AM - Seeking Alpha


Cubist Pharm. To Present At Morgan Stanley Conference; Webcast At 10:30 AM ET
9/8/2014 9:30:00 AM - RTT News


Cubist Pharmaceuticals Larger Than S&P 500 Component PerkinElmer
9/4/2014 3:43:38 PM - BNK Invest


Bullish Two Hundred Day Moving Average Cross - CBST
8/26/2014 10:42:06 AM - BNK Invest


Cubist Pharmaceuticals' Antibiotic Accepted for EU Review - Analyst Blog
8/25/2014 5:25:00 PM - Zacks.com


Did The Medicines Company Trump Cellceutix And Others In A $1B-Plus Skin Infection Market?
8/14/2014 11:38:00 AM - Seeking Alpha